《大行》大摩:小米(01810.HK)YU7表現成功 目標價62元籲「增持」
摩根士丹利發表研究報告指,小米-W(01810.HK)推出第二款電動車YU7,起售價為25.35萬元人民幣(下同),較SU7的價格高,該行料可為2025至26年的平均售價及利潤率帶來正面影響。另外,該行亦見到YU7的訂單量有驚喜,開售3分鐘即有20萬輛訂單,一小時內已有28.9萬輛,高於SU7開售4分鐘的1萬輛,及開售首27分鐘的5萬輛。
該行重申其看法,認為小米的電動車將為行業帶來衝擊,而YU7會是顯著的催化劑。該行亦曾強調預期至2030年,小米整體收入規模可達1萬億元,而淨利潤可達1,000億元。如是者,小米市值可達2.5萬億元,YU7的成功有助加速此進程。該行現予目標價62港元及「增持」評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.